PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CSIR-Central Drug Research Institute, Lucknow. Electronic address: r_ravishankar@cdri.res.in.\', \'CSIR-Central Drug Research Institute, Lucknow.\', \'King George\'s Medical University, Lucknow.\', \'ERA\'s Lucknow Medical College and Hospital.\', \'Ram Manohar Lohia Institute of Medical Sciences, Lucknow.\', \'CSIR-Central Drug Research Institute, Lucknow. Electronic address: director@cdri.res.in.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00872-910.1016/j.ijid.2021.11.025
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34801738
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34801738>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34801738>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all